India to Japan: Glimepiride Export Trade Route

The India to Japan Glimepiride corridor is one of India's established pharmaceutical export routes, with 42 shipments documented worth a combined $2.3M USD. The route is dominated by MEDREICH LIMITED, which alone accounts for roughly 78% of all export value, reflecting the consolidated nature of India's glimepiride manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $54.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with glimepiride's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 27.2%, placing it at rank #4 among India's top glimepiride export destinations globally.

On the import side, key buyers of Indian glimepiride in Japan include MEIJI SEIKA PHARMATECH CO LIMITED, MEIJI SEIKA PHARMATECH CO., LTD, MEIJI SEIKA PHARMA CO.LTD, ODAWARA and 6 others. MEIJI SEIKA PHARMATECH CO LIMITED is the single largest importer with 15 shipments valued at $818.7K USD.

India's glimepiride exports to Japan are driven primarily by a handful of large-scale manufacturers. MEDREICH LIMITED with 33 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Japan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MEDREICH LIMITED, MEDREICH LIMITED — together account for 100% of total trade value on this route. The average shipment value of $54.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as glimepiride 0.5mg tablets po no.mm-158- and glimepiride 1mg tablets, po no.mm-152, p , suggesting that buyers in Japan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MEIJI SEIKA PHARMATECH CO LIMITED is the largest importer with 15 shipments worth $818.7K USD — representing 36% of all glimepiride imports from India on this route. A total of 9 buyers are active on this corridor.